The University of California, Davis (DC Davis) is proposing to create a Clinical and Translational Science Center (CISC) which will transform our medical research enterprise into a highly effective """"""""open""""""""academic home for clinical and translational research by building on three key assets: 1) Our long-standing commitment as a land-grant university to serve the geographicallydisperse and ethnically diverse populations of inland and Northern California with a health care system enabled by one of the broadest and most extensive telecommunications programs in the world; 2) The collaborative culture of DC Davis, which has one of the most extensive and interdisciplinary life science environments in the country, and 3) An established CSTC pilot facility - the UCDavis Clinical Research Investigator Services Program (CRISP) that serves as the physical home for clinical and translational research and for faculty training andcareer development. CRISP is a fundamentally important CTSC testing ground, where many perceived CTSA barriers have been explored and solutions tested, and through CRISP, we have completed the planning phase for the CTSC. In the organizational structure of the UC Davis CTSC, considerable attention is paid to create an organization that is: 1) responsive and familiar to investigators; 2) flexible; 3) well linked to university leadership, to participating academicunits, and to the community; and 4) focused on the goal of reducing barriers and facilitating the translation of research gains into medical practice. Key features are: Education programfocused on """"""""team science""""""""; Extensivecollaborations across UC Davis colleges and centers; Introduction of catalyst functions such as CollaborativeResearch Facilitators and translational postdoctoral fellowships; Dissemination through tele-technology;Flexible use of resources for patient- oriented research; and a Community engagement program emphasizing trust and respect. The CTSC is under the leadership of two co-Principal Investigators, Drs. Berglund MD, PhD, (P.I.) and Joseph MD, PhD (co-P.I.), supported by a team of Directors and co-Directorsoverseeing each of the 9 CTSC programs, and a comprehensive committee structure, designed to firmly anchor the CTSC with institutional leadership, faculty, trainees and the community. The UC Davis CTSCwill be implemented through a carefully designed, collaborative plan, and the activity will be guided through continuous evaluations and corrections.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Linked Training Award (TL1)
Project #
5TL1RR024145-03
Application #
7485647
Study Section
Special Emphasis Panel (ZRR1-CR-A (01))
Program Officer
Sawczuk, Andrea
Project Start
2006-09-30
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
3
Fiscal Year
2008
Total Cost
$128,623
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Wang, Shuyun; Mundada, Lakshmi; Johnson, Sean et al. (2015) Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells. Stem Cells Transl Med 4:339-50
Hodonsky, Chani; Mundada, Lakshmi; Wang, Shuyun et al. (2015) Effects of scaffold material used in cardiovascular surgery on mesenchymal stem cells and cardiac progenitor cells. Ann Thorac Surg 99:605-11
Polage, Christopher R; Gyorke, Clare E; Kennedy, Michael A et al. (2015) Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era. JAMA Intern Med 175:1792-801
Luo, Zhen; Loja, Melissa N; Farwell, D Greg et al. (2014) Widefield optical imaging of changes in uptake of glucose and tissue extracellular pH in head and neck cancer. Cancer Prev Res (Phila) 7:1035-44
Roegner, Amber F; Puschner, Birgit (2014) Aggregate culture: A more accurate predictor of microcystin toxicity for risk assessment. Toxicon 83:1-14
Kost, Rhonda G; Lee, Laura N; Yessis, Jennifer L et al. (2014) Research participant-centered outcomes at NIH-supported clinical research centers. Clin Transl Sci 7:430-40
McDonnel, S J; Tell, L A; Murphy, B G (2014) Pharmacokinetics and pharmacodynamics of suberoylanilide hydroxamic acid in cats. J Vet Pharmacol Ther 37:196-200
Murphy, B; Hillman, C; McDonnel, S (2014) Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection. Virus Res 179:34-43
Loja, Melissa N; Luo, Zhen; Greg Farwell, D et al. (2013) Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer. Int J Cancer 132:1613-23
McDonnel, Samantha J; Sparger, Ellen E; Luciw, Paul A et al. (2012) Transcriptional regulation of latent feline immunodeficiency virus in peripheral CD4+ T-lymphocytes. Viruses 4:878-88

Showing the most recent 10 out of 17 publications